Low-Molecular-Weight-Heparin as Thromboprophylaxis: a Dosage Problem in Obese Patients
Journal of Research in Obesity
Background: Prophylaxis with fixed doses of low-molecular-weight heparin (LMWH) is standard procedure to reduce the risk of venous thromboembolism after surgery. Patient studies have rarely been stratified for body weight. There is evidence to suggest that lack of sufficient levels of anti-factor Xa-activity (anti-Xa) in…